To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Part 1 Dose Escalation of SLC-3010 Monotherapy and in Combination
Primary Objectives:
Secondary Objectives:
Part 2: Dose Expansion of SLC-3010 Monotherapy and in Combination
Patients must meet all the following inclusion criteria to be eligible for enrollment into the study:
Birth control methods unacceptable for this study include the following:
Individuals who meet any of the following exclusion criteria will not be eligible to participate:
Exceptions: (i) Malignancies that were treated curatively and have not recurred within the past 2 years, or (ii) Completely resected basal cell carcinoma and squamous cell carcinoma of the skin, or (iii) Completely resected carcinoma in situ of any type.